Investigation of in vitro response to TTFields and related gene expression in 45 human cell lines

Autor: Kinzel, A, Lavy-Shahaf, G, Giladi, M, Schneiderman, R, Gotlib, K, Zeevi, E, Porat, Y, Munster, M, Weinberg, U, Kirson, E, Palti, Y

Publikováno v: 71. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), 9. Joint Meeting mit der Japanischen Gesellschaft für Neurochirurgie; 20200621-20200624; sine loco [digital]; DOCV014 /20200626/

Objective: Previous investigations showed Tumour Treating Fields (TTFields) to have an inhibitory effect of variable extent in different cancer cell lines. In order to predict TTFields response better in the future, we conducted various analyses of s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b26c2c56be6f0d289fa4b2d259ccb6b

P-121 Effects of tumor treating fields (TTFields) on gastric cancer cells and their potential concomitant application with FOLFOX

Autor: Flint-Brodsly, N., Zeevi, E., Dor-On, E., Schneiderman, R., Munster, M., Porat, Y., Voloshin, T., Davidi, S., León, J., Haber, A., Giladi, M., Weinberg, U., Palti, Y.

Publikováno v: In Annals of Oncology June 2022 33 Supplement 4:S292-S293

P-184 Underlining mechanism for the efficacy of tumor treating fields (TTFields) concomitant with sorafenib for treatment of hepatocellular carcinoma

Autor: Davidi, S., Jacobovitch, S., Shteingauz, A., Tempel-Brami, C., Munster, M., Zeevi, E., Dor-On, E., Schneiderman, R., Voloshin, T., Haber, A., Giladi, M.

Publikováno v: In Annals of Oncology July 2021 32 Supplement 3:S162-S163

P-261 Safety and effectiveness of tumor treating fields combined with sorafenib in preclinical models of hepatocellular carcinoma

Autor: Davidi, S., Tempel-Brami, C., Munster, M., Gotlib, K., Zeevi, E., Schneiderman, R., Voloshin, T., Giladi, M., Weinberg, U., Palti, Y.

Publikováno v: In Annals of Oncology July 2020 31 Supplement 3:S175-S175

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.